IN8BIO, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
IN8BIO, INC. (INAB) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $287.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $140.00K, a 42.39% decline year-over-year.
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $147.00K, a 15.03% decline year-over-year.
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $157.00K, a 27.65% decline year-over-year.
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $157.00K, a 25.24% decline year-over-year.
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $730.00K, a 10.98% decline from fiscal 2024.
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $820.00K, a 22.75% increase from fiscal 2023.
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $668.00K, a 34.95% increase from fiscal 2022.
- IN8BIO, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $495.00K, a 205.56% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $287.00K 10-Q · filed 2026-08-06 | $444.00K derived: sum of 3 quarters · filed 2026-08-06 | $601.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $147.00K 10-Q · filed 2026-05-07 | $304.00K derived: sum of 2 quarters · filed 2026-05-07 | $461.00K derived: sum of 3 quarters · filed 2026-05-07 | $704.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $314.00K derived: sum of 2 quarters · filed 2026-03-12 | $557.00K derived: sum of 3 quarters · filed 2026-08-06 | $730.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $400.00K derived: sum of 2 quarters · filed 2026-08-06 | $573.00K 10-Q · filed 2025-11-06 | $790.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $416.00K 10-Q · filed 2026-08-06 | $633.00K derived: sum of 3 quarters · filed 2026-08-06 | $843.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $173.00K 10-Q · filed 2026-05-07 | $390.00K derived: sum of 2 quarters · filed 2026-05-07 | $600.00K derived: sum of 3 quarters · filed 2026-05-07 | $804.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $427.00K derived: sum of 2 quarters · filed 2026-03-12 | $631.00K derived: sum of 3 quarters · filed 2026-03-12 | $820.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $414.00K derived: sum of 2 quarters · filed 2025-11-06 | $603.00K 10-Q · filed 2025-11-06 | $778.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $393.00K 10-Q · filed 2025-08-07 | $568.00K derived: sum of 3 quarters · filed 2025-08-07 | $738.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $189.00K 10-Q · filed 2025-05-07 | $364.00K derived: sum of 2 quarters · filed 2025-05-07 | $534.00K derived: sum of 3 quarters · filed 2025-05-07 | $698.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $345.00K derived: sum of 2 quarters · filed 2025-03-13 | $509.00K derived: sum of 3 quarters · filed 2025-03-13 | $668.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $334.00K derived: sum of 2 quarters · filed 2024-11-12 | $493.00K 10-Q · filed 2024-11-12 | $648.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $323.00K 10-Q · filed 2024-08-08 | $478.00K derived: sum of 3 quarters · filed 2024-08-08 | $601.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $159.00K 10-Q · filed 2024-05-09 | $314.00K derived: sum of 2 quarters · filed 2024-05-09 | $437.00K derived: sum of 3 quarters · filed 2024-05-09 | $587.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $278.00K derived: sum of 2 quarters · filed 2024-03-14 | $428.00K derived: sum of 3 quarters · filed 2024-03-14 | $495.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $273.00K derived: sum of 2 quarters · filed 2023-11-09 | $340.00K 10-Q · filed 2023-11-09 | $407.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $217.00K 10-Q · filed 2023-08-10 | $284.00K derived: sum of 3 quarters · filed 2023-08-10 | $318.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $67.00K 10-Q · filed 2023-05-12 | $134.00K derived: sum of 2 quarters · filed 2023-05-12 | $168.00K derived: sum of 3 quarters · filed 2023-05-12 | $199.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $101.00K derived: sum of 2 quarters · filed 2023-03-30 | $132.00K derived: sum of 3 quarters · filed 2023-03-30 | $162.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $65.00K derived: sum of 2 quarters · filed 2022-11-10 | $95.00K 10-Q · filed 2022-11-10 | $95.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $61.00K 10-Q · filed 2022-08-12 | $61.00K derived: sum of 3 quarters · filed 2022-08-12 | $61.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $30.00K 10-Q · filed 2022-05-12 | $30.00K derived: sum of 2 quarters · filed 2022-05-12 | $30.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |